BR0304292A -
Estrogen-gestagen combination preparation and use
- Google Patents
Estrogen-gestagen combination preparation and use
Info
Publication number
BR0304292A
BR0304292ABR0304292ABR0304292ABR0304292ABR 0304292 ABR0304292 ABR 0304292ABR 0304292 ABR0304292 ABR 0304292ABR 0304292 ABR0304292 ABR 0304292ABR 0304292 ABR0304292 ABR 0304292A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm GmbhfiledCriticalSolvay Pharm Gmbh
Priority to BR0304292ApriorityCriticalpatent/BR0304292A/en
Publication of BR0304292ApublicationCriticalpatent/BR0304292A/en
"PREPARADO DE COMBINAçãO DE ESTROGêNIO-GESTAGêNIO E USO". A presente invenção refere-se a novos preparados de combinação de estrogênio-gestagênio, para uso na terapia de reposição hormonal, por exemplo, para uso em distúrbios da menopausa ou climatério."PREPARED FOR COMBINATION OF STROGEN-GESTAGEN AND USE". The present invention relates to novel estrogen-gestagen combination preparations for use in hormone replacement therapy, for example for use in menopausal or climacteric disorders.
BR0304292A2003-09-302003-09-30
Estrogen-gestagen combination preparation and use
BR0304292A
(en)
Fragments of beta amyloid peptide (ab) ab 1-7 and ab 3-7 linked to a carrier peptide, a pharmaceutical composition that comprises it and its use to treat Alzheimer's disease
17A- RENT- 17B- OXI-STRATRIENS AND INTERMEDIATE PRODUCTS FOR PREPARATION, USE OF THE 17A-RENT-17B-OXI-STRATRIENS TO OBTAIN PHARMACEUTICAL DRUGS AND PREPARATIONS.